Minimally-Invasive and Efficient Method to Accurately Fit the Bergman Minimal Model to Diabetes Type 2
Authors:
- Ana Gabriela Gallardo-HernándezAGAna Gabriela Gallardo-Hernández
- Marcos A. González-OlveraMGMarcos A. González-Olvera
- Medardo Castellanos-FuentesMCMedardo Castellanos-Fuentes
- Jésica EscobarJEJésica Escobar
- Cristina Revilla-MonsalveCRCristina Revilla-Monsalve
- Ana Luisa Hernandez-PerezAHAna Luisa Hernandez-Perez
- Ron LederRLRon Leder
- 2 February 2022
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Bioengineering
- Vol. 15 (3) , 267-279
Abstract
Introduction Diabetes mellitus is a global burden that is expected to grow \(25\%\) by 2030. This will increase the need for prevention, diagnosis and treatment of diabetes. Animal and individualized in silico models will allow understanding and compensation for inter and intra-individual differences in treatment and management strategies for diabetic patients. The method presented here can advance the concept of personalized medicine. Methods Twenty experiments were performed with Sprague-Dawley rats with streptozotocin induced experimental diabetes in which the insulin-glucose response curve was recorded over 60–100 min using only an insulin pump and a percutaneous glucose sensor. The information was used to fit the five-parameter Bergman Minimal Model to the experimental results using a genetic algorithm with a root-mean-squared optimization rule. Results The Bergman Minimal Model parameters were estimated with high accuracy, low prediction bias, and low average root-mean-squared error of 15.27 mg/dl glucose. Conclusions This study demonstrates a simple method to accurately parameterize the Bergman Minimal Model. We used Sprague–Dawley rats since their physiology is close to that of humans. The parameters can be used to objectively characterize the physiological severity of diabetes. In this way, planned treatments can compensate for natural variations of conditions both inter and intra patients. Changes in parameters indicate the patient’s diabetic condition using values of glucose effectiveness (\(S_{\text{G}}=p_1\)) and insulin sensitivity (\(S_I=p_3/p_2\)). Quantifying the diabetic patient’s condition is consistent with the trend toward personalized medicine. Parameter values can also be used to explain atypical research results of other studies and increase understanding of diabetes.
Keywords
Funding Information
- Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/G15/1419)
- Universidad Autónoma de la Ciudad de México (PI-CCyT-2021-12)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (CB-2009-128251)
This publication has 42 references indexed in Scilit:
- Stress hyperglycemia: an essential survival response!Critical Care, 2013
- Genetic algorithm based NARX model identification for evaluation of insulin sensitivityApplied Soft Computing, 2011
- Weighting Restriction for Intravenous Insulin Delivery on T1DM Patient via $H_{\infty}$ ControlIEEE Transactions on Automation Science and Engineering, 2009
- Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Blood glucose regulation using higher‐order sliding mode controlInternational Journal of Robust and Nonlinear Control, 2007
- Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimationClinical Science, 2007
- An improved genetic algorithm with conditional genetic operators and its application to set-covering problemSoft Computing, 2006
- Minimal Model: Perspective from 2005Hormone Research in Paediatrics, 2005
- An overview of evolutionary algorithms: practical issues and common pitfallsInformation and Software Technology, 2001
- Measuring the predictive performance of computer-controlled infusion pumpsJournal of Pharmacokinetics and Biopharmaceutics, 1992